Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044109 · ClinicalTrials.gov registry record · Phase 2
Magnets in the Treatment of Sciatica
A Phase 2 study of Low Back Pain and Sciatica, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00044109: Completed Phase 2 study of Low Back Pain and Sciatica, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
NCT00044109 is a Phase 2 study of Low Back Pain and Sciatica that has completed, run by National Institute of Dental and Craniofacial Research (NIDCR). The registered enrollment target is 75 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00044109, a Phase 2 study of Low Back Pain and Sciatica, has completed, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite much popularity among the public, magnetic devices used for the treatment of various musculoskeletal and neuropathic pain syndromes have been the subject of few randomized controlled trials. We propose to study the effects of permanent 200 gauss magnets on lumbar radicular pain. This study will include 52 men and women of all ethnic backgrounds between the ages of 28 and 75 who have had signs and symptoms of sciatica for 3 months or more. This is a double-blind, randomized, placebo-control, two phase study. In the first phase, after one week baseline, subjects will be randomized to 4 different treatments in a cross-over design. These 4 treatments which will last two weeks each are: 1 magnetic device positioned in 2 different ways along the spinal axis (up-down along the lumbo-sacral spine and left-right across the lumbo-sacral spine), a sham device of similar configuration and a no treatment control. The length of phase I will be 8 weeks. At the end of this phase, codes will be broken to select the magnetic device associated with the greatest amount of pain score reduction. During the second phase which will also be double-blinded, subjects will be randomized to wear the selected magnetic device and sham in a cross-over design. Each of the 2 periods will be 5 weeks in duration. The primary outcome measures will be the daily pain score in the leg. Daily pain level in the low back and the back and leg combined in addition to the patients' quality of life and activities of daily living will be secondary outcome measures as assessed by the SF 36, Oswestry, and Beck depression inventory.
Conditions Studied
Interventions
- DEVICE Magnets
Study Locations (1)
Maryland
- National Institute of Dental And Craniofacial Research (NIDCR) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-06 |
| Phase | Phase 2 |
What the finished NCT00044109 record still lists
NCT00044109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Magnets is the first listed.
NCT00044109 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00044109 about?
NCT00044109 is a clinical study titled "Magnets in the Treatment of Sciatica". Despite much popularity among the public, magnetic devices used for the treatment of various musculoskeletal and neuropathic pain syndromes have been the subject of few randomized controlled trials. We propose to study the effects of permanent 200 gauss magnets on lumbar radicular pain. This study ...
What is the current status of trial NCT00044109?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2002-08. Estimated completion is 2006-06.
What conditions does trial NCT00044109 study?
This clinical trial studies the following conditions: Low Back Pain, Sciatica.
What interventions are being tested in trial NCT00044109?
The interventions under investigation include: Magnets (DEVICE).
Who is sponsoring clinical trial NCT00044109?
This trial is sponsored by National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00044109 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00044109's enrollment target sits among peer trials
75 70th of 122 higher than 52 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dronabinol as an Adjunct for Reducing Pain
RECRUITING · Phase 2
-
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)
RECRUITING · Phase 2
-
D-cycloserine in the Management of Chronic Low Back Pain
COMPLETED · Phase 2
-
Pregnancy-Related Low Back Pain and Complementary and Alternative Medicine (CAM) Treatment
COMPLETED · Phase 2
-
Endogenous Opioid Response to Injections
RECRUITING · Phase 4
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia